Occurrence of adverse events after magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) therapy in symptomatic uterine fibroids—a retrospective case-control study

References

• Stewart EA, Cookson CL, Gandolfo RA, et al. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017;124(10):1501–1512.
   PubMed Web of Science ®Google Scholar
• Bulun SE. Uterine fibroids. N Engl J Med. 2013;369(14):1344–1355.
   PubMed Web of Science ®Google Scholar
• Stewart EA, Laughlin-Tommaso SK, Catherino WH, et al. Uterine fibroids. Nat Rev Dis Primers. 2016;2:16043.
   PubMed Web of Science ®Google Scholar
• Giuliani E, As-Sanie S, Marsh EE. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet. 2020;149(1):3–9.
   PubMed Web of Science ®Google Scholar
• Qin H, Lin Z, Vásquez E, et al. Association between obesity and the risk of uterine fibroids: a systematic review and meta-analysis. J Epidemiol Community Health. 2021;75(2):197–204.
   PubMed Web of Science ®Google Scholar
• Huseman-Plascencia LA, Villa-Villagrana F, Ballesteros-Manzo A, et al. Body mass index and vitamin D as risk factors for the development of uterine leiomyomas in Mexican women. J Endometriosis Pelvic Pain Disord. 2022;14(1):14–18.
   Web of Science ®Google Scholar
• Vilos GA, Allaire C, Laberge PY, et al. The management of uterine leiomyomas. J Obstet Gynaecol Can. 2015;37(2):157–178.
   PubMed Web of Science ®Google Scholar
• Costa AR, Carvalho AP, Martins DR, et al. Series of 55 pregnancies following ulipristal acetate treatment of symptomatic uterine fibroids. J Endometriosis Pelvic Pain Disord. 2020;12(3-4):170–175.
   Web of Science ®Google Scholar
• Flynn M, Jamison M, Datta S, et al. Health care resource use for uterine fibroid tumors in the United States. Am J Obstet Gynecol. 2006;195(4):955–964.
   PubMed Web of Science ®Google Scholar
• Al-Hendy A, Myers ER, Stewart E. Uterine fibroids: burden and unmet medical need. Semin Reprod Med. 2017;35(6):473–480.
   PubMed Web of Science ®Google Scholar
• Soliman AM, Yang H, Du EX, et al. The direct and indirect costs of uterine fibroid tumors: a systematic review of the literature between 2000 and 2013. Am J Obstet Gynecol. 2015;213(2):141–160.
   PubMed Web of Science ®Google Scholar
• Taran FA, Tempany CM, Regan L, et al. Magnetic resonance-guided focused ultrasound (MRgFUS) compared with abdominal hysterectomy for treatment of uterine leiomyomas. Ultrasound Obstet Gynecol. 2009;34(5):572–578.
   PubMed Web of Science ®Google Scholar
• Anneveldt KJ, van’t Oever HJ, Nijholt IM, et al. Systematic review of reproductive outcomes after high intensity focused ultrasound treatment of uterine fibroids. Eur J Radiol. 2021;141:109801.
   PubMed Web of Science ®Google Scholar
• Akhatova A, Aimagambetova G, Bapayeva G, et al. Reproductive and obstetric outcomes after UAE, HIFU, and TFA of uterine fibroids: systematic review and meta-analysis. Int J Environ Res Public Health. 2023;20(5):4480.
   PubMedGoogle Scholar
• Daniels J, Middleton LJ, Cheed V, et al. Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT. Health Technol Assess. 2022;26(22):1–74.
   Web of Science ®Google Scholar
• Anneveldt KJ, Nijholt IM, Schutte JM, et al. Comparison of (cost-)effectiveness of magnetic resonance image-guided high-intensity-focused ultrasound with standard (minimally) invasive fibroid treatments: protocol for a multicenter randomized controlled trial (MYCHOICE). JMIR Res Protoc. 2021;10(11):e29467.
   PubMed Web of Science ®Google Scholar
• Verpalen IM, de Boer JP, Linstra M, et al. The Focused Ultrasound Myoma Outcome Study (FUMOS); a retrospective cohort study on long-term outcomes of MR-HIFU therapy. Eur Radiol. 2020;30(5):2473–2482.
   PubMed Web of Science ®Google Scholar
• Quinn SD, Vedelago J, Gedroyc W, et al. Safety and five-year re-intervention following magnetic resonance-guided focused ultrasound (MRgFUS) for uterine fibroids. Eur J Obstet Gynecol Reprod Biol. 2014;182:247–251.
   PubMed Web of Science ®Google Scholar
• Kociuba J, Łoziński T, Zgliczyńska M, et al. Adverse events and complications after magnetic resonance-guided focused ultrasound (MRgFUS) therapy in uterine fibroids – a systematic review and future perspectives. Int J Hyperthermia. 2023;40:2174274.
   PubMedGoogle Scholar
• Verpalen IM, Anneveldt KJ, Nijholt IM, et al. Magnetic resonance-high intensity focused ultrasound (MR-HIFU) therapy of symptomatic uterine fibroids with unrestrictive treatment protocols: a systematic review and meta-analysis. Eur J Radiol. 2019;120:108700.
   PubMed Web of Science ®Google Scholar
• Lozinski T, Filipowska J, Pyka M, et al. Magnetic resonance-guided high-intensity ultrasound (MR-HIFU) in the treatment of symptomatic uterine fibroids - five-year experience. Ginekol Pol. 2022;93(3):185–194.
   Web of Science ®Google Scholar
• Łoziński T, Ciebiera M, Łuczyńska E, et al. Magnetic resonance-guided high-intensity focused ultrasound ablation of uterine fibroids-efficiency assessment with the use of dynamic contrast-enhanced magnetic resonance imaging and the potential role of the administration of uterotonic drugs. Diagnostics (Basel). 2021;11(4):715.
   PubMedGoogle Scholar
• Łoziński T, Ludwin A, Filipowska J, et al. Oxytocin and misoprostol with diclofenac in the preparation for magnetic resonance-guided high-intensity ultrasound treatment of symptomatic uterine fibroids: a prospective cohort study. Ultrasound Med Biol. 2021;47(6):1573–1585.
   PubMed Web of Science ®Google Scholar
• Funaki K, Sawada K, Maeda F, et al. Subjective effect of magnetic resonance-guided focused ultrasound surgery for uterine fibroids. J Obstet Gynaecol Res. 2007;33(6):834–839.
   PubMed Web of Science ®Google Scholar
• Funaki K, Fukunishi H, Funaki T, et al. Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: relationship between the therapeutic effects and signal intensity of preexisting T2-weighted magnetic resonance images. Am J Obstet Gynecol. 2007;196(2):184.e1–184.e6.
   PubMedGoogle Scholar
• Khalilzadeh O, Baerlocher MO, Shyn PB, et al. Proposal of a new adverse event classification by the society of interventional radiology standards of practice committee. J Vasc Interv Radiol. 2017;28(10):1432–1437.e3.
   PubMed Web of Science ®Google Scholar
• Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs. 2005;14(7):798–804.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang ZB, Xu YH. Efficacy, efficiency, and safety of magnetic resonance-guided high-intensity focused ultrasound for ablation of uterine fibroids: comparison with ultrasound-guided method. Korean J Radiol. 2018;19(4):724–732.
   PubMed Web of Science ®Google Scholar
• Chen R, Keserci B, Bi H, et al. The safety and effectiveness of volumetric magnetic resonance-guided high-intensity focused ultrasound treatment of symptomatic uterine fibroids: early clinical experience in China. J Ther Ultrasound. 2016;4:27.
   PubMed Web of Science ®Google Scholar
• Park MJ, Kim YS, Rhim H, et al. Safety and therapeutic efficacy of complete or near-complete ablation of symptomatic uterine fibroid tumors by MR imaging-guided high-intensity focused US therapy. J Vasc Interv Radiol. 2014;25(2):231–239.
   PubMed Web of Science ®Google Scholar
• Brown DL, Hesley GK, Gorny KR, et al. Safety of mr-guided focused ultrasound treatment of pedunculated subserosal uterine leiomyomas. J Ther Ultrasound. 2013;1(1):19.
   Google Scholar
• Wang Y, Gong C, He M, et al. Therapeutic dose and long-term efficacy of high-intensity focused ultrasound ablation for different types of uterine fibroids based on signal intensity on T2-weighted MR images. Int J Hyperthermia. 2023;40(1):2194594.
   PubMed Web of Science ®Google Scholar
• Duc NM, Keserci B. Review of influential clinical factors in reducing the risk of unsuccessful MRI-guided HIFU treatment outcome of uterine fibroids. Diagn Interv Radiol. 2018;24(5):283–291.
   PubMed Web of Science ®Google Scholar
• Zhao WP, Chen JY, Zhang L, et al. Feasibility of ultrasound-guided high intensity focused ultrasound ablating uterine fibroids with hyperintense on T2-weighted MR imaging. Eur J Radiol. 2013;82(1):e43–e49.
   PubMed Web of Science ®Google Scholar
• Mindjuk I, Trumm CG, Herzog P, et al. MRI predictors of clinical success in MR-guided focused ultrasound (MRgFUS) treatments of uterine fibroids: results from a single Centre. Eur Radiol. 2015;25(5):1317–1328.
   PubMed Web of Science ®Google Scholar
• Inbar Y, Machtinger R, Barnett-Itzhaki Z, et al. MRI guided focused ultrasound (MRgFUS) treatment for uterine fibroids among women with and without abdominal scars. Int J Hyperthermia. 2021;38(1):1672–1676.
   PubMed Web of Science ®Google Scholar
• Stewart EA, Gedroyc WM, Tempany CM, et al. Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique. Am J Obstet Gynecol. 2003;189(1):48–54.
   PubMed Web of Science ®Google Scholar
• Tsai MC, Chang LT, Tam KW. Comparison of high-intensity focused ultrasound and conventional surgery for patients with uterine myomas: a systematic review and meta-analysis. J Minim Invasive Gynecol. 2021;28(10):1712–1724.
   PubMed Web of Science ®Google Scholar
• Barnard EP, AbdElmagied AM, Vaughan LE, et al. Periprocedural outcomes comparing fibroid embolization and focused ultrasound: a randomized controlled trial and comprehensive cohort analysis. Am J Obstet Gynecol. 2017;216(5):500.e1–500.e11.
   PubMed Web of Science ®Google Scholar
• Ikink ME, Nijenhuis RJ, Verkooijen HM, et al. Volumetric MR-guided high-intensity focused ultrasound versus uterine artery embolisation for treatment of symptomatic uterine fibroids: comparison of symptom improvement and reintervention rates. Eur Radiol. 2014;24(10):2649–2657.
   PubMed Web of Science ®Google Scholar
• Liu L, Wang T, Lei B. Uterine artery embolization compared with high-intensity focused ultrasound ablation for the treatment of symptomatic uterine myomas: a systematic review and meta-analysis. J Minim Invasive Gynecol. 2021;28(2):218–227.
   PubMed Web of Science ®Google Scholar
• Jeng CJ, Long CY, Chuang LT. Comparison of magnetic resonance-guided high-intensity focused ultrasound with uterine artery embolization for the treatment of uterine myoma: a systematic literature review and meta-analysis. Taiwan J Obstet Gynecol. 2020;59(5):691–697.
   PubMed Web of Science ®Google Scholar
• Liang D, Li J, Liu D, et al. Comparison of thermal ablative methods and myomectomy for the treatment of fibroids: a systematic review and meta-analysis. Int J Hyperthermia. 2021;38(1):1571–1583.
   PubMed Web of Science ®Google Scholar
• Okada A, Morita Y, Fukunishi H, et al. Non-invasive magnetic resonance-guided focused ultrasound treatment of uterine fibroids in a large Japanese population: impact of the learning curve on patient outcome. Ultrasound Obstet Gynecol. 2009;34(5):579–583.
   PubMed Web of Science ®Google Scholar